Copyright Reports & Markets. All rights reserved.

Global Prostaglandin D2 Receptor 2 Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Prostaglandin D2 Receptor 2 Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Prostaglandin D2 Receptor 2 Market Size Growth Rate by Product
      • 1.4.2 OC-2417
      • 1.4.3 MK-1029
      • 1.4.4 BBI-5000
      • 1.4.5 ADC-7405
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Prostaglandin D2 Receptor 2 Market Size Growth Rate by End User
      • 1.5.2 Atopic Dermatitis
      • 1.5.3 Allergic Asthma
      • 1.5.4 Chronic Obstructive Pulmonary Disease
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Prostaglandin D2 Receptor 2 Market Size
      • 2.1.1 Global Prostaglandin D2 Receptor 2 Revenue 2014-2025
      • 2.1.2 Global Prostaglandin D2 Receptor 2 Sales 2014-2025
    • 2.2 Prostaglandin D2 Receptor 2 Growth Rate by Regions
      • 2.2.1 Global Prostaglandin D2 Receptor 2 Sales by Regions
      • 2.2.2 Global Prostaglandin D2 Receptor 2 Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Prostaglandin D2 Receptor 2 Sales by Manufacturers
      • 3.1.1 Prostaglandin D2 Receptor 2 Sales by Manufacturers
      • 3.1.2 Prostaglandin D2 Receptor 2 Sales Market Share by Manufacturers
      • 3.1.3 Global Prostaglandin D2 Receptor 2 Market Concentration Ratio (CR5 and HHI)
    • 3.2 Prostaglandin D2 Receptor 2 Revenue by Manufacturers
      • 3.2.1 Prostaglandin D2 Receptor 2 Revenue by Manufacturers (2014-2019)
      • 3.2.2 Prostaglandin D2 Receptor 2 Revenue Share by Manufacturers (2014-2019)
    • 3.3 Prostaglandin D2 Receptor 2 Price by Manufacturers
    • 3.4 Prostaglandin D2 Receptor 2 Manufacturing Base Distribution, Product Types
      • 3.4.1 Prostaglandin D2 Receptor 2 Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Prostaglandin D2 Receptor 2 Product Type
      • 3.4.3 Date of International Manufacturers Enter into Prostaglandin D2 Receptor 2 Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Prostaglandin D2 Receptor 2 Sales by Product
    • 4.2 Global Prostaglandin D2 Receptor 2 Revenue by Product
    • 4.3 Prostaglandin D2 Receptor 2 Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Prostaglandin D2 Receptor 2 Breakdown Data by End User

    6 North America

    • 6.1 North America Prostaglandin D2 Receptor 2 by Countries
      • 6.1.1 North America Prostaglandin D2 Receptor 2 Sales by Countries
      • 6.1.2 North America Prostaglandin D2 Receptor 2 Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Prostaglandin D2 Receptor 2 by Product
    • 6.3 North America Prostaglandin D2 Receptor 2 by End User

    7 Europe

    • 7.1 Europe Prostaglandin D2 Receptor 2 by Countries
      • 7.1.1 Europe Prostaglandin D2 Receptor 2 Sales by Countries
      • 7.1.2 Europe Prostaglandin D2 Receptor 2 Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Prostaglandin D2 Receptor 2 by Product
    • 7.3 Europe Prostaglandin D2 Receptor 2 by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Prostaglandin D2 Receptor 2 by Countries
      • 8.1.1 Asia Pacific Prostaglandin D2 Receptor 2 Sales by Countries
      • 8.1.2 Asia Pacific Prostaglandin D2 Receptor 2 Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Prostaglandin D2 Receptor 2 by Product
    • 8.3 Asia Pacific Prostaglandin D2 Receptor 2 by End User

    9 Central & South America

    • 9.1 Central & South America Prostaglandin D2 Receptor 2 by Countries
      • 9.1.1 Central & South America Prostaglandin D2 Receptor 2 Sales by Countries
      • 9.1.2 Central & South America Prostaglandin D2 Receptor 2 Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Prostaglandin D2 Receptor 2 by Product
    • 9.3 Central & South America Prostaglandin D2 Receptor 2 by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Prostaglandin D2 Receptor 2 by Countries
      • 10.1.1 Middle East and Africa Prostaglandin D2 Receptor 2 Sales by Countries
      • 10.1.2 Middle East and Africa Prostaglandin D2 Receptor 2 Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Prostaglandin D2 Receptor 2 by Product
    • 10.3 Middle East and Africa Prostaglandin D2 Receptor 2 by End User

    11 Company Profiles

    • 11.1 Allergan Plc
      • 11.1.1 Allergan Plc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Allergan Plc Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Allergan Plc Prostaglandin D2 Receptor 2 Products Offered
      • 11.1.5 Allergan Plc Recent Development
    • 11.2 Brickell Biotech, Inc.
      • 11.2.1 Brickell Biotech, Inc. Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Brickell Biotech, Inc. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Brickell Biotech, Inc. Prostaglandin D2 Receptor 2 Products Offered
      • 11.2.5 Brickell Biotech, Inc. Recent Development
    • 11.3 Ligand Pharmaceuticals, Inc.
      • 11.3.1 Ligand Pharmaceuticals, Inc. Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Ligand Pharmaceuticals, Inc. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Ligand Pharmaceuticals, Inc. Prostaglandin D2 Receptor 2 Products Offered
      • 11.3.5 Ligand Pharmaceuticals, Inc. Recent Development
    • 11.4 Merck & Co., Inc.
      • 11.4.1 Merck & Co., Inc. Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Merck & Co., Inc. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Merck & Co., Inc. Prostaglandin D2 Receptor 2 Products Offered
      • 11.4.5 Merck & Co., Inc. Recent Development
    • 11.5 Novartis AG
      • 11.5.1 Novartis AG Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Novartis AG Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Novartis AG Prostaglandin D2 Receptor 2 Products Offered
      • 11.5.5 Novartis AG Recent Development
    • 11.6 Oxagen Limited
      • 11.6.1 Oxagen Limited Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Oxagen Limited Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Oxagen Limited Prostaglandin D2 Receptor 2 Products Offered
      • 11.6.5 Oxagen Limited Recent Development
    • 11.7 Panmira Pharmaceuticals, LLC.
      • 11.7.1 Panmira Pharmaceuticals, LLC. Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Panmira Pharmaceuticals, LLC. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Panmira Pharmaceuticals, LLC. Prostaglandin D2 Receptor 2 Products Offered
      • 11.7.5 Panmira Pharmaceuticals, LLC. Recent Development
    • 11.8 Pulmagen Therapeutics LLP
      • 11.8.1 Pulmagen Therapeutics LLP Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Pulmagen Therapeutics LLP Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Pulmagen Therapeutics LLP Prostaglandin D2 Receptor 2 Products Offered
      • 11.8.5 Pulmagen Therapeutics LLP Recent Development
    • 11.9 Taisho Pharmaceutical Holdings Co., Ltd.
      • 11.9.1 Taisho Pharmaceutical Holdings Co., Ltd. Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Taisho Pharmaceutical Holdings Co., Ltd. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Taisho Pharmaceutical Holdings Co., Ltd. Prostaglandin D2 Receptor 2 Products Offered
      • 11.9.5 Taisho Pharmaceutical Holdings Co., Ltd. Recent Development

    12 Future Forecast

    • 12.1 Prostaglandin D2 Receptor 2 Market Forecast by Regions
      • 12.1.1 Global Prostaglandin D2 Receptor 2 Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Prostaglandin D2 Receptor 2 Revenue Forecast by Regions 2019-2025
    • 12.2 Prostaglandin D2 Receptor 2 Market Forecast by Product
      • 12.2.1 Global Prostaglandin D2 Receptor 2 Sales Forecast by Product 2019-2025
      • 12.2.2 Global Prostaglandin D2 Receptor 2 Revenue Forecast by Product 2019-2025
    • 12.3 Prostaglandin D2 Receptor 2 Market Forecast by End User
    • 12.4 North America Prostaglandin D2 Receptor 2 Forecast
    • 12.5 Europe Prostaglandin D2 Receptor 2 Forecast
    • 12.6 Asia Pacific Prostaglandin D2 Receptor 2 Forecast
    • 12.7 Central & South America Prostaglandin D2 Receptor 2 Forecast
    • 12.8 Middle East and Africa Prostaglandin D2 Receptor 2 Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Prostaglandin D2 Receptor 2 Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Prostaglandin D2 Receptor 2 market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Prostaglandin D2 Receptor 2 market based on company, product type, end user and key regions.

      This report studies the global market size of Prostaglandin D2 Receptor 2 in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Prostaglandin D2 Receptor 2 in these regions.
      This research report categorizes the global Prostaglandin D2 Receptor 2 market by top players/brands, region, type and end user. This report also studies the global Prostaglandin D2 Receptor 2 market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Allergan Plc
      Brickell Biotech, Inc.
      Ligand Pharmaceuticals, Inc.
      Merck & Co., Inc.
      Novartis AG
      Oxagen Limited
      Panmira Pharmaceuticals, LLC.
      Pulmagen Therapeutics LLP
      Taisho Pharmaceutical Holdings Co., Ltd.

      Market size by Product
      OC-2417
      MK-1029
      BBI-5000
      ADC-7405
      Others
      Market size by End User
      Atopic Dermatitis
      Allergic Asthma
      Chronic Obstructive Pulmonary Disease
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Prostaglandin D2 Receptor 2 market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Prostaglandin D2 Receptor 2 market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Prostaglandin D2 Receptor 2 companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Prostaglandin D2 Receptor 2 submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Prostaglandin D2 Receptor 2 are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Prostaglandin D2 Receptor 2 market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now